Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
03/2012
03/29/2012US20120077830 Caspase inhibitors and uses thereof
03/29/2012US20120076732 Phosphodiesterase inhibitors and uses thereof
03/28/2012EP2432764A1 Substituted quinolines for use as vegf inhibitors
03/28/2012EP2432556A1 Protease inhibitors
03/28/2012EP2148862B1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
03/28/2012EP2121615B1 Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one as agonist of the beta 2 adrenergic receptor
03/28/2012EP1603883B1 Quinoline-derived amide modulators of vanilloid vr1 receptor
03/28/2012CN102395565A Compounds having antiparasitic or anti-infectious activity
03/28/2012CN102391222A Novel hydroxamates as therapeutic agents
03/28/2012CN102391107A Method for preparing gallic acid quinolone drug salt and preparation method thereof
03/27/2012US8143402 Polymorphic forms of a macrocyclic inhibitor of HCV
03/27/2012US8143276 4-thio substituted quinoline and naphthyridine compounds
03/27/2012US8143259 Cold menthol receptor antagonists
03/22/2012WO2012037204A1 Inhibitors of pi3k-delta and methods of their use and manufacture
03/22/2012WO2012036520A2 Novel antibiotically active compound and an antibiotic composition comprising the compound
03/22/2012US20120071654 Aryl aniline derivatives as beta2 adrenergic receptor agonists
03/22/2012US20120071505 Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress
03/22/2012US20120071504 Modulators of cystic fibrosis transmembrane conductance regulator
03/22/2012US20120071503 Positive allosteric modulators of group ii mglurs
03/22/2012US20120071502 Novel phenoxyisobutyric acid compounds and methods for synthesis
03/22/2012US20120071466 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
03/22/2012CA2812089A1 Inhibitors of pi3k-delta and methods of their use and manufacture
03/21/2012EP2429991A1 Redox drug derivatives
03/21/2012EP2049493B1 Compounds suitable as modulators of hdl
03/21/2012EP1361215B1 Process for producing quinoline carboxyaldehyde derivative and intermediate thereof
03/21/2012CN1984895B Synthesis and uses of synephrine derivatives
03/21/2012CN102388024A Malate salt of n- (4- { [ 6, 7-bis (methyloxy) quin0lin-4-yl] oxy}phenyl-n' - (4 -fluorophenyl) cyclopropane-1-dicarboxamide, and crystalline forms therof for the treatment of cancer
03/21/2012CN102382050A Preparation method of substituted 1, 2, 3 and 4- tetrahydroquinoline -4-one hydrochloride
03/21/2012CN102379872A Compounds, compositions and methods of inhibiting a-synuclein toxicity
03/21/2012CN101611010B Process for the preparation of 8-hydroxy-5-[(1r)-1-hydroxy-2[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]-ethyl]-2(1h)-quinolinone monohydrochloride
03/21/2012CN101124206B 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
03/20/2012US8138346 Method for synthesis of 8-alkoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones
03/20/2012CA2672656C Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
03/20/2012CA2553423C Heterocyclic compounds for use in the treatment of cancer and the inhibition of angiogenesis
03/20/2012CA2493225C Quinoline derivatives and their use as mycobacterial inhibitors
03/20/2012CA2405076C Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof
03/15/2012WO2012034055A2 Compounds as c-met kinase inhibitors
03/15/2012WO2012033061A1 Organic electroluminescent element and charge transport material
03/15/2012WO2012032952A1 Compound having antimalarial activity and antimalarial drug
03/15/2012WO2012031993A1 Novel n-hydroxy-benzamides for the treatment of cancer
03/15/2012WO2012031358A1 Biaryl diphosphine ligands, intermediates of the same and their use in asymmetric catalysis
03/15/2012WO2011133659A3 Inhibitors of hif and angiogenesis
03/15/2012US20120065204 Novel n-hydroxy-benzamids for the treatment of cancer
03/15/2012US20120064099 Compounds that inhibit nfkb and bace1 activity
03/15/2012US20120064032 Novel hydroxamates as therapeutic agents
03/15/2012CA2810528A1 Compounds as c-met kinase inhibitors
03/15/2012CA2809736A1 N-hydroxy-benzamides for the treatment of cancer
03/14/2012EP2428506A1 Heterocyclic substituted acardite derivates and use thereof
03/14/2012EP2427434A1 Process for preparing bromo-substituted quinolines
03/14/2012EP2427430A1 5-oxo-ete receptor antagonist compounds
03/14/2012EP2075310B1 Organic electroluminescent device material and organic electroluminescent device
03/14/2012EP1888604B1 Process for preparing (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
03/14/2012CN102372756A Specific glucocorticosteroid compound having anti-inflammatory activity
03/14/2012CN102372672A Low-hygroscopicity aripiprazole crystal IV, its preparation method and application
03/14/2012CN102372671A Preparation method for 2-methylquinoline
03/13/2012US8134004 Substituted N-bicyclicalkyl bicycliccarboxyamide compounds
03/13/2012US8133882 Quinolone derivative or pharmaceutically acceptable salt thereof
03/13/2012CA2643097C Amine derivatives
03/13/2012CA2553231C Amine salt of carbostyril derivative
03/08/2012WO2012029763A1 Diamine, polyimide precursor, polyimide, liquid-crystal alignment material, liquid-crystal alignment film, and liquid-crystal display element
03/08/2012WO2012028233A1 Imidazo[4,5-c]quinolines as dna-pk inhibitors
03/08/2012US20120058945 Neuroprotective iron chelators and pharmaceutical compositions comprising them
03/08/2012CA2809553A1 Imidazo[4,5-c]quinolines as dna-pk inhibitors
03/07/2012EP2426191A1 Process for the homogenous hydrogenation of (poly)unsaturated hydrocarbons
03/07/2012EP2426115A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/07/2012EP2424918A2 Cure accelerators for anaerobic curable compositions
03/07/2012EP1352650B1 Inhibitors against the production and release of inflammatory cytokines
03/07/2012CN102369203A Herbicidal compounds
03/07/2012CN101845024B Compound for preparing montelukast sodium
03/06/2012US8129533 Method for production of quinolone-containing lyophilized preparation
03/06/2012US8129532 Amino(oligo)thiophene dyes, preparation thereof, and optical methods of use
03/06/2012US8129529 UV excitable fluorescent energy transfer dyes
03/01/2012WO2012025939A1 Pitavastatin calcium and process for its preparation
03/01/2012WO2012025239A1 Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as kcnq2/3 modulators
03/01/2012WO2012025238A1 Substituted quinoline-3-carboxamides as kcnq2/3 modulators
03/01/2012WO2012025237A1 Substituted 2-amino-quinoline-3-carboxamides as kcnq2/3 modulators
03/01/2012WO2012025236A1 Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators
03/01/2012US20120053206 Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as KCNQ2/3 modulators
03/01/2012US20120053205 Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators
03/01/2012US20120053204 Substituted quinoline-3-carboxamides as KCNQ2/3 modulators
03/01/2012US20120053197 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
03/01/2012US20120053192 Heterocyclic Substituted Acardite Derivate and Application Thereof
03/01/2012DE102010035744A1 Imidazolonylchinoline Imidazolonylchinoline
03/01/2012CA2809341A1 Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators
03/01/2012CA2809287A1 Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as kcnq2/3 modulators
03/01/2012CA2805932A1 Substituted 2-amino-quinoline-3-carboxamides as kcnq2/3 modulators
03/01/2012CA2804824A1 Substituted quinoline-3-carboxamides as kcnq2/3 modulators
02/2012
02/29/2012EP2423195A1 Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof
02/29/2012CN101781246B Improved method for synthesizing Aripiprazole
02/29/2012CN101574347B Aripiprazole medicinal agent of low hygroscopicity and methods for its preparing
02/28/2012US8124775 Tetrahydroquinoline compound; cardiovascular disorders; arteriosclerosis
02/28/2012US8124774 Therapeutic ((phenyl)imidazolyl)methylquinolinyl compounds
02/28/2012US8124625 Method of enhancing the expression of apolipoprotein AI using olefin derivatives
02/28/2012US8124623 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials
02/23/2012WO2012024132A2 Solution-processable electron-transport materials and related organic optoelectronic devices
02/23/2012US20120046307 Allosteric protein kinase modulators
02/23/2012US20120046304 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
02/23/2012US20120046274 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
02/23/2012US20120046250 Methods and compositions useful in treating cancer and reducing wnt mediated effects in a cell
02/22/2012EP2231614B1 Quinoline derivatives and their use as fungicides
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 277